In the present study, we further found that the PI3K inhibitor LY294002 significantly up-regulated HBP1 expression with a concomitant decrease in FOXO1 phosphorylation in HSC-3 oral cancer cells (Figure 3A–3B). Here, FOXO1 is linked to lip and oral cavity carcinoma.